Company Invites Biocore Co., Ltd.

Equities

A216400

KR7216400002

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per Business

Sales per region

Sector Bio Diagnostics & Testing

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
8,880 ^KRW	-0.11%		-2.42%	-4.52%

2023	CrystalGenomics Invites Co., LTD. agreed to acquire an 89.95% stake in PROCAGEN from Invites Biocore Co., Ltd. and others for KRW 13.1 billion	CI
2023	Invites Healthcare Co., Ltd. agreed to acquire Invites Genomics Co., Ltd. from Invites Biocore Co., Ltd. for KRW 10 billion	CI

Invites Biocore Co Ltd, formerly BioCore Co Ltd, is a Korea-based company mainly engaged in the provision of medical examination services. The Company operates its business through two segments. The New Drug Development Business segment is involved in the provision of bioequivalence testing, drug in vivo kinetics research, drug analysis in biological samples, toxicity kinetics testing, microanalysis in pharmaceuticals, comparative dissolution testing, and clinical trial consulting. The Biotechnology Business segment is engaged in the provision of customized genome analysis services and the manufacture and sale of diagnostic kits. The Companyâs products are sold under the brand of Bio-Core.

KRW in Million	2022	Weight	2023	Weight	Delta
New Drug Development 55.5 %	16,828	66.4 %	12,390	55.5 %	-26.37%
Biotechnology 44.5 %	8,529	33.6 %	9,929	44.5 %	+16.40%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 99.4 %	24,730	97.5 %	22,188	99.4 %	-10.28%
Overseas 0.6 %	627	2.5 %	130	0.6 %	-79.22%

Managers	Title	Age	Since
Moon-Ki Hong DFI	Director of Finance/CFO	50	-
Seung-Yong Hwang CTO	Chief Tech/Sci/R&D Officer	58	14-11-30
Ho-Young Lee HRO	Human Resources Officer	60	13-05-31
Seok-Joon Yang AUD	Comptroller/Controller/Auditor	59	17-12-31

Members of the board	Title	Age	Since
Seung-Yong Hwang CTO	Chief Tech/Sci/R&D Officer	58	14-11-30
Dong-Gyu Ahn BRD	Director/Board Member	63	-
Yong-Gyu Shin CHM	Chairman	56	-
Si-hyung Park BRD	Director/Board Member	43	20-03-24
Hoon Jang BRD	Director/Board Member	66	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	7,711,315	4,529,612 ( 58.74 %)	53,165 ( 0.6894 %)	58.74 %
Stock B	0	1,541,850	0	0

Invites Biocore Co., Ltd.

8/F, IT Mirae Tower 33 Digital-ro 9-gil

08511, Seoul

http://www.bio-core.com

address Invites Biocore Co., Ltd.(A216400)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Diagnostics & Testing

	1st Jan change	Capi.
INVITES BIOCORE CO., LTD.	-4.52%	50.55M
EXACT SCIENCES CORPORATION	-14.37%	11.41B
IOVANCE BIOTHERAPEUTICS, INC.	+70.73%	3.81B
GUARDANT HEALTH, INC.	-29.39%	2.3B
BGI GENOMICS CO., LTD.	-12.90%	2.16B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+37.56%	1.19B
SEEGENE, INC.	-2.40%	760M
CAREDX, INC	-15.17%	506M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-34.29%	444M
CURIOX BIOSYSTEMS CO., LTD	+13.72%	339M

Bio Diagnostics & Testing